|4Mar 4, 4:25 PM ET

Cox Christopher T 4

4 · MEDICINES CO /DE · Filed Mar 4, 2019

Insider Transaction Report

Form 4
Period: 2019-02-28
Cox Christopher T
EVP & Chief Corp. Dev. Officer
Transactions
  • Award

    Common Stock

    2019-02-28$20.97/sh+317$6,64760,625 total
Holdings
  • Common Stock

    (indirect: See footnote)
    334,955
Footnotes (2)
  • [F1]Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2018 and ending February 28, 2019. In accordance with the terms of the ESPP, these share were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 28, 2019.
  • [F2]The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -